Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis

NCT01749787 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: PRTX-100 at 1.5 mcg/kg
DRUG: PRTX-100 at 3.0 mcg/kg
DRUG: PRTX-100 at 6.0 mcg/kg
DRUG: PRTX-100 at 12.0 mcg/kg
DRUG: PRTX-100 at 240 mcg
DRUG: Placebo
DRUG: PRTX-100 at 420 mcg

Sponsor

Protalex, Inc.